Arterial Spin Labeling — Labeling Scheme Techniques and Parameters

Arterial Spin Labeling — Labeling Scheme Techniques and Parameters

MRIninja Knowledge Base | Technical Child Page — Deep Dive Parent Master: Arterial Spin Labeling (ASL) — Generic Standard Protocol (9301) Version 1.0 — September 2026

1. Executive Summary

The ASL generic master page establishes the consensus-standard clinical protocol — PCASL labeling, background suppression, 3D segmented readout, M0 calibration — built around the 2015/2023 ISMRM Perfusion Study Group recommendations. This child page assumes that generic protocol as already known and does not repeat it. Its scope is narrower and more technical: a detailed, parameter-by-parameter explanation of the different labeling scheme options available on modern MRI consoles, their vendor-specific sub-parameters, and how each one is actually used — content directly requested to cover every ASL-specific parameter visible on a real console, cross-checked against the equivalent terminology on other major vendor platforms.

This page is anchored throughout by real console data reviewed directly from a Philips system's Advanced Parameters panel, spanning four distinct labeling configurations available on that platform: ASL_SinglePhase and ASL_MultiPhase (both using the STAR pulsed labeling scheme), pCASL (pseudo-continuous labeling), and 4D-TRANCE (STAR Angio labeling repurposed for non-contrast MR angiography). These four represent the two fundamental ASL labeling physics families in clinical use — pulsed and pseudo-continuous — plus their perfusion and angiographic applications.

1.1 Scope of This Child Page

Covered here: the physical meaning of every labeling-scheme-specific sub-parameter (label thickness, label gap, label delay, label distance, post-label delay, phases, duration, phase interval, label type); the cross-vendor terminology mapping for each; typical values and the clinical consequence of changing each one; and worked examples drawn from real acquired protocols. Not repeated here (see the parent master instead): general patient preparation, the full clinical indications list, the mandatory core sequence table, reporting templates, and the PCASL-specific consensus quantification model already developed in full in Section 10 of the parent master.

2. Labeling Scheme Families — Overview and Cross-Vendor Terminology

2.1 The Two Fundamental Labeling Physics Families

Every ASL labeling scheme belongs to one of two physically distinct families, a distinction that determines which sub-parameters are even meaningful to set:

Pulsed ASL (PASL family) — a single short (5–20 ms) adiabatic inversion RF pulse tags a thick slab of blood at one instant in time. The tagged bolus then has a fixed, finite spatial extent that decays as it flows toward the imaging volume. Philips' STAR ("Signal Targeting by Alternating Radiofrequency pulses") and FAIR ("Flow-sensitive Alternating Inversion Recovery") are both PASL-family implementations, as confirmed directly on the console's own help documentation [1,4,5]. The sub-parameters that matter for this family describe the geometry of the tagged slab: its thickness, its distance (gap) from the imaging volume, and the delay before imaging (functionally equivalent to the inversion time, TI, in the general PASL literature).

Pseudo-continuous ASL (pCASL) — a train of hundreds of short RF pulses combined with gradient blips, applied continuously over roughly 1.5–2 seconds at a thin labeling plane, achieves flow-driven adiabatic inversion of blood as it crosses that plane (the full physics is developed on the parent master, Section 10.1). Because labeling here is a continuous process at a plane rather than an instantaneous pulse over a slab, its sub-parameters are conceptually different: the distance from the labeling plane to the imaging volume, and the post-label delay (PLD) — the wait time after labeling ends before imaging begins.

This is not a minor technical distinction — it is the reason the two families expose entirely different sub-parameter names on every vendor's console, and confusing one family's parameters for the other's is the single most common source of protocol-translation error for this page (Section 9).

2.2 Master Cross-Vendor Terminology Table

Terminology below is cross-checked against the 2024 ISMRM Open Science Initiative for Perfusion Imaging (OSIPI) ASL Lexicon consensus report, which was developed specifically to harmonise ASL terminology across the divergent implementations that emerged after the 2015 consensus [3], alongside vendor-specific literature.

Vendor terminology confirmed directly from an actual Philips console (Advanced Parameters, Motion tab, Arterial Spin labeling section): all sub-parameter names in the Philips column above were read directly from the scanner, across four distinct saved protocols (ASL_SinglePhase, ASL_MultiPhase, pCASL, 4D-TRANCE) [console review]. The console's own built-in help documentation was also directly reviewed and confirms the following official definitions: pCASL = "pseudo Continuous Arterial Spin Labeling"; STAR = "Signal Targeting by Alternating Radio frequency pulses"; STAR Angio = the same STAR technique applied to non-contrast brain angiography; FAIR = "Flow-sensitive Alternating Inversion Recovery"; Time-SLIP = "Time Spatial Labeling Inversion Pulse," described as a non-contrast-enhanced MR angiography technique [console help].

3. PASL-Family Parameters in Detail (STAR / FAIR)

3.1 Label Thickness (mm)

Physical meaning: the thickness, along the labeling axis, of the single adiabatic inversion pulse's tagged slab. A thicker slab tags a larger initial volume of arterial blood.

Typical values observed: 130 mm for standard perfusion-oriented STAR protocols (ASL_SinglePhase and ASL_MultiPhase, both reviewed directly); up to 300 mm for the angiography-oriented STAR Angio/4D-TRANCE configuration, where labeling a much larger arterial volume is desirable to visualise the full intracranial arterial tree over multiple downstream phases.

Effect of increasing: more labeled blood volume, generally improving perfusion signal, but at some cost to labeling efficiency uniformity across a thicker slab and increased sensitivity to the transmit RF field's spatial uniformity over the larger tagged region.

Effect of decreasing: a smaller, more spatially well-defined bolus, at the cost of less total labeled signal.

3.2 Label Gap (mm)

Physical meaning: the distance left between the edge of the tagged slab and the near edge of the imaging volume. This gap exists for the same fundamental reason the parent master's Section 4.6 explains for the pCASL labeling plane: it ensures the labeling pulse's own imperfect spatial profile (see the companion Slice Gap deep dive for the general RF-profile-transition-band mechanism) does not partially saturate brain tissue at the near edge of the imaging volume.

Typical values observed: 20 mm across every STAR-family configuration reviewed (SinglePhase, MultiPhase, and the STAR Angio/4D-TRANCE configuration) — a consistent Philips default regardless of the clinical application.

Effect of an inadequate gap: partial saturation of brain tissue at the labeling-side edge of the imaging volume, directly analogous to the "too close to the imaging volume" labeling-plane error already catalogued for pCASL on the parent master (Section 8.4 there).

3.3 Label Delay (ms) — the PASL Equivalent of Inversion Time (TI)

Physical meaning: the time from the single inversion pulse to the start of image acquisition — functionally equivalent to the inversion time (TI) in the general PASL literature and OSIPI lexicon [3]. This is the PASL-family counterpart of pCASL's post-label delay (Section 4.2), though the two are not numerically interchangeable, since PASL's bolus begins decaying immediately from a single instantaneous pulse, while pCASL's bolus is still being actively labeled during part of its own timing window.

Typical values observed: 1200 ms for the standard single-phase STAR perfusion protocol; a much shorter starting value of 300 ms for the multi-phase STAR protocol, where this is the delay to the first of several sampled phases rather than a single fixed delay (Section 5).

Clinical consequence of an inadequate label delay: exactly the arterial-transit-artefact mechanism already developed in depth on the parent master (Section 5.1 there) — if the label delay is shorter than the true arterial transit time to a given territory, labeled blood remains intravascular rather than having exchanged into tissue, producing the characteristic serpentine/gyriform artefact rather than a smooth CBF map.

3.4 FAIR-Specific Considerations

FAIR achieves the tag/control contrast differently from STAR: the "tag" image uses a slab-selective inversion (similar to STAR), while the "control" image uses a non-selective (whole-volume) inversion, so that static tissue is inverted identically in both images and subtracts away, leaving only the flow-dependent signal from blood that has moved between the labeling and imaging volumes [4]. FAIR's sub-parameters (thickness, delay) follow the same general logic as STAR's, but FAIR is intrinsically more sensitive to the uniformity of the non-selective inversion pulse across the whole coil volume — a consideration not present for STAR's single-slab-only design.

4. pCASL Parameters in Detail

4.1 Label Distance (mm)

Physical meaning: the distance between the pCASL labeling plane and the near edge of the imaging volume — the Philips-specific single-value parameter corresponding to the more elaborate labeling-plane-positioning process described in full anatomical/technical detail on the parent master (Section 4.6 there: C2/C3 level, perpendicular to ICA/VA, ≥ 20 mm gap to the imaging volume).

Value observed: 90 mm on the reviewed pCASL protocol — substantially larger than the STAR-family label gap (20 mm), reflecting the fundamentally different geometry: pCASL's labeling plane sits at the neck (C2/C3), genuinely distant from a brain imaging volume, while STAR's tagged slab is immediately adjacent to the imaging volume with only a small buffer gap.

4.2 Post Label Delay (ms)

Physical meaning: the wait time after the end of the continuous labeling train before imaging begins — the PLD already developed extensively on the parent master (Section 10.1 there), including its role in the consensus quantification kinetic model.

Value observed: 1800 ms on the reviewed pCASL protocol — matching exactly the parent master's consensus-recommended PLD for healthy patients under 70 years old at 3T (Section 10.1 of the parent master), confirming this console's default pCASL configuration is aligned with the 2015/2023 ISMRM consensus.

4.3 Labeling Duration — Not Separately Exposed on This Console

Unlike Siemens and GE, which expose labeling duration (LD) as a directly editable parameter (Section 2.2), the specific Philips protocol card reviewed for this page did not display a separate, user-editable labeling duration field for pCASL — only label distance and post label delay were shown. This does not mean labeling duration is not a real, operative parameter internally (it is fundamental to the pCASL physics developed on the parent master); it means this particular console's operator-facing interface may fix it at a default value or expose it only in a deeper settings tier not captured in the reviewed screenshots. Operators translating a protocol to or from a Siemens/GE platform, where LD is directly editable, should confirm the equivalent value with local physics support rather than assuming it is absent.

5. Multi-Phase (Time-Resolved) ASL Parameters

5.1 Phases

Physical meaning: the number of separate images acquired at different points in time relative to the labeling pulse, within a single ASL acquisition. A "phases = 1" configuration is standard single-delay ASL, functionally identical to the single-PLD approach the parent master presents as the consensus clinical default. A "phases > 1" configuration acquires multiple time points, functionally equivalent to the multi-PLD acquisition the parent master already discusses as a conditional sequence for steno-occlusive disease, Moyamoya, and elderly patients (Section 4.2 of the parent master).

Values observed: 1 phase on the standard ASL_SinglePhase protocol; 8 phases on both the ASL_MultiPhase perfusion protocol and the 4D-TRANCE angiographic protocol.

5.2 Duration (ms) — Total Multi-Phase Sampling Window

Physical meaning: the total time span over which the multiple phases are sampled, from the first to the last time point.

Values observed: 4000 ms on the perfusion-oriented ASL_MultiPhase protocol (8 phases spanning a 4-second window); 1850 ms on the angiography-oriented 4D-TRANCE protocol (8 phases spanning a shorter, ~1.85-second window, appropriate for capturing the faster dynamics of arterial inflow for angiographic contrast rather than the slower tissue-perfusion signal).

5.3 Phase Interval (ms)

Physical meaning: the time spacing between consecutive sampled phases — effectively the "step size" of the time-resolved sampling, directly analogous in concept to the spacing between post-label delays in a research multi-PLD ASL protocol.

Values observed: 250 ms (user-defined) on the ASL_MultiPhase perfusion protocol; 200 ms (user-defined) on the 4D-TRANCE angiographic protocol — both set to "user defined" mode rather than a fixed default, indicating this is a parameter the operator is expected to actively choose based on the clinical question (finer temporal sampling for more precise transit-time characterisation, at a cost in total phases needed to cover the same overall duration).

5.4 Clinical Rationale — Time-Resolved CBF and Hemodynamic Sampling

Multi-phase ASL serves the same fundamental clinical purpose as the multi-PLD acquisition already developed on the parent master: correcting for arterial transit time bias by sampling the perfusion signal at several time points rather than assuming a single fixed delay is adequate for every patient and territory. It is the direct technical implementation of the "multi-PLD" concept the parent master flags as important for steno-occlusive disease, Moyamoya, and elderly patients (Section 4.2, Section 11 of the parent master), differing from a purely research-grade multi-PLD implementation mainly in vendor-specific naming ("phases"/"phase interval" rather than a list of discrete PLD values) and in its availability as a standard, saved clinical protocol on this console.

6. Angiographic ASL-Derived Techniques (STAR Angio, Time-SLIP, 4D-TRANCE)

6.1 Shared Physics, Different Application

STAR Angio and Time-SLIP use the same fundamental labeling physics as perfusion-oriented STAR and FAIR (Section 3) — magnetically tagging arterial blood without any exogenous contrast agent — but repurposed to visualise the arterial tree itself (a high-resolution angiographic image) rather than to quantify tissue-level blood flow. 4D-TRANCE is Philips' clinical product name for this application, explicitly described in the console's own help documentation as producing "high resolution multi-phase 3D angiography images" for "brain angiography without the use of contrast agent" [console help].

6.2 Parameter Differences vs. Perfusion-Oriented ASL

The 4D-TRANCE protocol reviewed directly for this page illustrates exactly how the same underlying labeling parameters (Section 3) are re-tuned for an angiographic rather than perfusion application:

6.3 4D-TRANCE Worked Example

The complete 4D-TRANCE protocol reviewed for this page: STAR Angio labeling, parallel slab type, label thickness 300 mm, label gap 20 mm, label delay 200 ms, 8 phases, total duration 1850 ms, phase interval 200 ms (user defined); 140 slices at 1.22 × 1.30 × 1.30 mm resolution, transverse orientation, relative SNR 1.02, total scan time 5:37. This single protocol produces a time-resolved, non-contrast 3D angiographic dataset — a genuine gadolinium-free alternative to contrast-enhanced MRA for patients in whom contrast is contraindicated or undesirable, directly extending the parent master's "no contrast requirement" core strength (Section 1.1 of the parent master) from tissue perfusion into vascular imaging.

7. Practical Optimisation Strategies — Choosing a Labeling Scheme

Choose pCASL as the default for routine clinical perfusion imaging, consistent with the parent master's consensus-based recommendation (Section 4.3 of the parent master) — higher, more consistent labeling efficiency and better SNR than PASL-family techniques, at the cost of a somewhat more demanding labeling-plane-positioning step (Section 4.6 of the parent master).

Consider STAR/FAIR (PASL-family) where pCASL is unavailable, where rapid protocol setup is prioritised, or on platforms/field strengths where pCASL labeling efficiency is compromised (e.g. some lower-field or older-generation systems) — the well-defined, geometrically simple slab-based tagging of STAR/FAIR requires no separate neck-level labeling-plane planning step, at some cost to quantification robustness relative to pCASL (Section 3.3).

Use multi-phase (time-resolved) STAR, or a research multi-PLD pCASL protocol, whenever arterial transit time is a genuine clinical concern — steno-occlusive disease, Moyamoya, elderly patients — following the same clinical logic already established on the parent master (Section 11 there), rather than defaulting to single-phase/single-PLD acquisition for every patient regardless of pre-test probability of delayed transit.

Select STAR Angio/Time-SLIP (4D-TRANCE-type protocols) specifically when the clinical question is vascular anatomy rather than tissue perfusion — AVM feeding-vessel characterisation, non-invasive intracranial arterial assessment when gadolinium is contraindicated — recognising that this is a distinct clinical application from the perfusion-oriented ASL protocols developed throughout the parent master, sharing only the underlying labeling physics.

8. MRI Technologist Pearls

Know which labeling family a saved protocol uses before touching any sub-parameter — a "label delay" field belongs to the STAR/FAIR (PASL) family; a "post label delay" field belongs to pCASL. They are not interchangeable, and adjusting one while thinking of the other's physics will produce an incorrect acquisition.

When switching a saved protocol from single-phase to multi-phase (or vice versa), re-check every sub-parameter — label delay, phases, duration, and phase interval all change together as a coordinated set (Section 5), not independently.

For angiographic (STAR Angio/Time-SLIP/4D-TRANCE) protocols, do not import perfusion-protocol label delay or label thickness values by habit — the angiographic timing priorities are fundamentally different (Section 6.2), and using perfusion-appropriate values will produce a poor angiographic result.

9. Common Avoidable Errors

10. Quality Control Checklist Addendum

In addition to the full QC checklist on the parent master (Section 9 there), for any protocol built on the labeling-scheme parameters covered in this page:

• Labeling scheme identified and documented: STAR / FAIR / pCASL / STAR Angio / Time-SLIP
• For STAR/FAIR: label thickness, label gap, and label delay all confirmed appropriate for the clinical question (perfusion vs. angiographic timing priorities, Section 6.2)
• For pCASL: label distance and post label delay confirmed consistent with the parent master's consensus values (Section 10.1 of the parent master) unless a documented clinical reason justifies deviation
• For multi-phase protocols: phases, duration, and phase interval verified as an internally consistent set (Section 5, Section 9 of this page)
• For angiographic (4D-TRANCE-type) protocols: resolution and slice count confirmed adequate for 3D/MIP vessel rendering, distinct from perfusion-protocol resolution standards

11. Evidence Gaps and Ongoing Debate

Direct, prospective head-to-head comparison of STAR/FAIR versus pCASL labeling efficiency and CBF quantification accuracy across current-generation vendor implementations remains comparatively limited, particularly for the specific console software versions and field strengths in routine current clinical use — most published comparative data predates the most recent generation of pCASL implementations that have become the default across major vendors since the 2015 consensus.

Standardised nomenclature adoption remains incomplete in practice: although the 2024 OSIPI ASL Lexicon [3] provides consensus terminology, individual vendor consoles — as directly documented in this page's cross-vendor table (Section 2.2) — continue to use platform-specific field names that do not always map one-to-one onto the lexicon's recommended terms, and clinical reports/protocols do not yet uniformly adopt the harmonised nomenclature.

Clinical validation of multi-phase/time-resolved STAR specifically (as opposed to multi-PLD pCASL, which has more published validation) against reference-standard perfusion measurement is less extensively documented in the peer-reviewed literature, despite being a standard, vendor-supported clinical protocol option on at least the platform reviewed for this page.

12. Evidence-Based References

A. Guidelines / Consensus / Society Recommendations

C. Important Prospective / Original Studies

E. Landmark Historical References

End of document — Arterial Spin Labeling — Labeling Scheme Techniques and Parameters — MRIninja v1.0 — September 2026